| Literature DB >> 36011421 |
Nicole Camoni1,2, Silvia Cirio2, Claudia Salerno2, Araxi Balian2,3, Giulia Bruni2, Valeria D'Avola2, Maria Grazia Cagetti2.
Abstract
Telemedicine is becoming a standard method of consultation, and the COVID-19 pandemic has increased its need. Telemedicine is suitable for non-communicable diseases (NCDs) in the pediatric population, as these are chronic conditions that affect many children worldwide. The aim of this study was to analyze the bibliometric parameters of publications on the use of telemedicine for the most common NCDs in children before and after the COVID-19 pandemic. Following the electronic search, 585 records were selected. "Metabolic diseases" was the most frequent topic before and after the pandemic, accounting for 34.76% in 2017-2019 and 33.97% in 2020-2022. The average IF of the journals from which records were retrieved was 5.46 ± 4.62 before and 4.58 ± 2.82 after the pandemic, with no significant variation. The number of citations per reference averaged 14.71 ± 17.16 in 2017-2019 (95% CI: 12.07; 17.36) and 5.54 ± 13.71 in 2020-2022 (95% CI: 4.23; 6.86). Asthma, metabolic diseases, and neurodevelopmental disorders were the most explored topics. A relevant finding concerns the increasing number of observational studies after the pandemic, with a reduction of the interventional studies. The latter type of study should be recommended as it can increase the evaluation of new strategies for the management of NCDs.Entities:
Keywords: bibliometric analysis; non-communicable diseases; pediatrics; telemedicine
Mesh:
Year: 2022 PMID: 36011421 PMCID: PMC9407809 DOI: 10.3390/ijerph19169787
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1PRISMA flowchart of the selection process and classification process by topic of the included records.
Data comparison according to publication years.
| Variable | Publication Years 2020–2022 | Publication Years 2017–2019 | |
|---|---|---|---|
| ( | ( | ||
|
| |||
| Africa | 3 (0.71%) | 0 (0.00%) | 0.001 * |
| Asia | 46 (10.93%) | 7 (4.26%) | |
| Europe | 110 (26.13%) | 42 (25.61%) | |
| Oceania | 11 (2.61%) | 17 (10.37%) | |
| North America | 225 (53.44%) | 88 (53.66%) | |
| South America | 14 (3.33%) | 5 (3.05%) | |
| More than one continent | 12 (2.85%) | 5 (3.05%) | |
| Total | 421 (100.00%) | 164 (100.00%) | |
|
| |||
| Journal article | 331 (78.62%) | 132 (80.49%) | 0.183 |
| Book chapter | 0 (0.00%) | 1 (0.61%) | |
| Comment/editorial/letter | 11 (2.62%) | 7 (4.27%) | |
| Conference abstract | 79 (18.76%) | 24 (14.63%) | |
| Total | 421 (100.00%) | 164 (100.00%) | |
|
| |||
| Asthma | 77 (18.29%) | 39 (23.78%) | <0.001 * |
| Brain disorders | 44 (10.45%) | 5 (3.05%) | |
| Dental caries | 13 (3.09%) | 12 (7.32%) | |
| Mental disorders | 26 (6.18%) | 18 (10.98%) | |
| Metabolic diseases | 143 (33.97%) | 57 (34.76%) | |
| Neurodevelopmental diseases or disorders | 108 (25.65%) | 25 (15.24%) | |
| Skin diseases | 10 (2.37%) | 8 (4.87%) | |
| Total | 421 (100.00%) | 164 (100.00%) | |
|
| |||
| Case report/case series | 14 (3.33%) | 3 (1.83%) | <0.001 * |
| Guidelines/consensus paper | 7 (1.66%) | 2 (1.22%) | |
| Interventional study | 131 (31.12%) | 82 (50.00%) | |
| Observational study | 146 (34.68%) | 31 (18.90%) | |
| Review/Meta-analysis | 108 (25.65%) | 33 (20.12%) | |
| Study protocol/pilot study | 15 (3.56%) | 13 (7.93%) | |
| Total | 421 (100.00%) | 164 (100.00%) | |
|
| |||
| Prevention | 9 (2.13%) | 2 (1.22%) | 0.109 |
| Diagnosis | 38 (9.03%) | 17 (10.37%) | |
| Treatment | 149 (35.39%) | 73 (44.51%) | |
| Follow up | 176 (41.81%) | 50 (30.49%) | |
| Diagnosis and treatment/follow- up | 49 (11.64%) | 22 (13.41%) | |
| Total | 421 (100.00%) | 164 (100.00%) |
* p-Value <0.05 derived by 2-tailed Fisher’s exact test for categorical data.
Figure 2Prevalence of records published in different countries.
Comparison of bibliometric variables according to publication years.
| Variable |
| Mean | 95% CI | SD | Range | |
|---|---|---|---|---|---|---|
|
| ||||||
| 2020–2022 | 421 | 5.54 | 4.23; 6.86 | 13.71 | 0.00–192.00 | <0.001 * |
| 2017–2019 | 164 | 14.71 | 12.07; 17.36 | 17.16 | 0.00–79.00 | |
|
| ||||||
| 2020–2022 | 359 | 4.58 | 4.28; 4.87 | 2.82 | 0.06–21.60 | 0.709 |
| 2017–2019 | 135 | 5.46 | 4.67; 6.24 | 4.62 | 0.27–32.07 | |
Figure 3Frequency of type of studies according to publication year.
Figure 4Bibliometric visualization of term co-occurrence map. Terms cited more than 200 times are shown according to the number of occurrences (circle size), year of highest occurrence (color), and co-occurrence between them (link).